Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Research Grant, 2016
    Chronic Effects of Low Frequency Deep Brain Stimulation on Aspiration, Freezing of Gait and Other Axial and Motor Symptoms in Parkinson's Disease

    Study Rationale:
    Our recent study (Xie et al., Neurology. 2015;84:415-420) found that 60Hz stimulation, compared to the traditional 130Hz, decreased aspiration frequency and swallowing difficulty...

  • Biomarkers Across Neurodegenerative Diseases, 2016
    Homo- and Hetero-aggregates as Biomarkers in Neurodegenerative Disorders

    Study Rationale:
    Neurodegenerative disorders like Alzheimer's and Parkinson's disease often have overlapping symptoms, which can make it difficult to differentiate them from one another in the clinic...

  • Target Advancement Program, 2016
    Identifying Enzymes to Stimulate Alpha-synuclein Degradation

    Study Rationale:
    Rab GTPases, a family of small molecules that guide protein movement around cells, are linked to Parkinson's disease (PD). We have identified a group of Rabs with potential roles in...

  • Research Grant, 2016
    Defining Structural Forms of Alpha-synuclein Responsible for Key Features Associated with Parkinson's Disease

    Study Rationale:
    The alpha-synuclein pre-formed fibril (PFF) model shows promise for modeling many features of Parkinson’s disease (PD). In this model, PFFs induce pathological features and behaviors...

  • Research Grant, 2016
    Therapeutic Effects of XPro1595 on Motor and Non-motor Outcomes in a Pre-clinical Model of Parkinson's disease

    Study Rationale:
    Studies funded under the 2012 TDI award revealed that peripheral administration of XPro1595 in the 6-OHDA (neurotoxin) pre-clinical model afforded significant neuroprotection against...

  • Improved Biomarkers and Clinical Outcome Measures, 2016
    Defining a Parkinson's Disease-specific Breath Fingerprint of Inflammatory and Neurodegenerative Processes

    Study Rationale:
    Breath analysis has the potential to be a powerful non-invasive screening tool to help a clinician determine the need for additional tests, a tool for routine interval screening of...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.